Effectiveness and safety of secukinumab in axial spondyloarthritis and psoriatic arthritis: A retrospective analysis of its real-world usage from India
Background: Although secukinumab has become available in India since mid-2016, there is no published data on its usage in axial spondyloarthritis (axial SpA) and psoriatic arthritis (PsA). In this study, we analyzed the real-world usage of this drug to assess the effectiveness and safety in axial Sp...
Saved in:
| Main Authors: | Sham Santhanam, Hema Murugesan, Thilagavthy Nambi, Raja Natarajan, Kavitha Mohanasundaram |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=4;spage=261;epage=266;aulast=Santhanam |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01) -
Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: E. E. Gubar, et al.
Published: (2025-06-01) -
Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study
by: Ploysyne Rattanakaemakorn, et al.
Published: (2024-11-01) -
Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: Е. Е. Gubar, et al.
Published: (2024-04-01) -
Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab
by: Ebru Atalar, et al.
Published: (2025-06-01)